Global Vision
Waton Corporation, based in Ginza, Japan, focuses on the clinical application and dissemination of regenerative medicine. With the long-term strategic core of “rooted in Japan, deeply cultivated in Taiwan, radiating across Asia,” our goal is not only to export technology but also to promote medical standards, ethical values, and the spirit of public welfare. Amid Asia’s aging population and growing health awareness, we are advancing regenerative medicine from Japanese clinical settings into everyday life worldwide, making “health regeneration” no longer a privilege of hospitals but a reality accessible to everyone.
From Ginza, we set forth to let the light of life sciences illuminate all of Asia.
Japan | The Starting Point of Technology and Trust
Japan is our hub for technology and clinical standards. It is not only the birthplace of our stem cell and PRP therapies but also the starting point for establishing our regenerative medicine quality standards.
- Collaborating with the University of Tokyo Medical School on Clinical Trials
- Kyoto Cell Research Center (CiRA) Exosome Collaboration Project
- Operating under the Japanese Ministry of Health, Labour and Welfare's regenerative medicine regulatory and approval system.
- GMP Standard Laboratory + AI Medical Monitoring Platform
Japan represents "precision" and "trust," which are the cornerstones of the entire ecosystem.
Taiwan | A Bridgehead for Asian Health Technology
Taiwan is positioned as our second growth engine in our Asian strategy. It not only connects to the Chinese-speaking market but also facilitates the translation and localization of clinical findings from Japan.
Main areas of cooperation:
- Collaboration with medical universities in Japan
- Jointly developing AI health algorithms and stem cell applications with the School of Pharmacy
- Established a "Public Welfare Volunteer Group" and a "Member Health Platform" to promote health education for all.
- Jointly establish the "Asian Regenerative Medicine Database"
Taiwan is a hub where technology and culture resonate.
In the pan-Asian region, we uphold the concept of "inclusive healthcare" and transform regenerative medicine into accessible, affordable, and implementable health services.
Cooperation and Implementation Models:
- Singapore: Collaborating with the Institute for Biotechnology Research (A*STAR) on AI health prediction models
- Malaysia: Establishing a Clinical Training Center for Regenerative Medicine
- Thailand: Promoting BitHealth Payment and Cross-border Health Membership Program
Core strategy:
- Local medical education and technical training
- Public Welfare Testing and Mobile Medical Services Program
- Regenerative Medicine Experience Center (Experiential Health Testing + Digital Consultant)
Let our medical technology reach every family across Asia.
League of Nations
Our collaborative ecosystem brings together partners from four major systems: scientific research, clinical practice, industry, and public welfare.
Category | Key Partners | Cooperation Content |
Academic research | University of Tokyo / Kyoto CiRA / National Cheng Kung University School of Medicine | Clinical research on stem cells and exosomes |
Medical Clinical | Chang Gung Memorial Hospital / National Hospital of Singapore | Clinical applications of regenerative medicine |
Industry Alliance | Japan Pharmaceutical Manufacturers Association / Taiwan Biotechnology Association | Technology transfer and formulation development |
Public welfare cooperation | Japan-Taiwan Health Volunteer Alliance / Asia Charitable Medical Foundation | Free testing, health education, and social care |
The integration of technology, healthcare, and philanthropy is our core strategy.
Global data and clinical sharing
We have created "WATON Global Health Cloud"—Asia's first multinational regenerative medicine data cloud system.
Functions and value:
- Integrating clinical data from Japan, Taiwan, and Southeast Asia
- Supports AI-powered real-time health analysis and prediction
- Provide case tracking and treatment recommendations to collaborating physicians
- Promote academic exchange and international clinical validation
Transparency in data makes healthcare smarter, more precise, and more trustworthy.
Public welfare strategy
Waton Corporation launched the "Project ReGene" and the "Health Together Asia" projects.
The plan includes:
- Providing door-to-door health screenings for the elderly and people with mobility difficulties in rural areas
- The joint volunteer team provides medical education and health lectures
- Provide regenerative medicine assistance to low-income families and patients with chronic diseases
"Technology heals the body, philanthropy heals the soul."
Development Blueprint
Stage | Development Goals | Key Milestone |
2025–2026 | Foundation Consolidation Period | The clinical systems in Japan and Taiwan are operating stably. | Completed cooperation with 5 medical institutions, and reached 500,000 members. |
2026–2028 | Accelerated Expansion Period | Southeast Asian market expansion and AI platform implementation | Establish regional operation centers and develop more than 5 patents. |
2029–2032 | Global Ecological Period | Becoming a top regenerative medicine group in Asia | Global membership surpasses 5 million; main board listing plan completed. |
